• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与奥沙利铂、5-氟尿嘧啶和亚叶酸联合化疗相关的间质性肺疾病]

[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].

作者信息

Park Sul, Jung Jae Jin, Kim Goeng Bae, Yoon Hyung Sik, Ko Sang Hun, Ko Jae Ee, Lee Yeun Seun

机构信息

Department of Internal Medicine, Sun General Hospital, Daejeon, Korea.

出版信息

Korean J Gastroenterol. 2010 May;55(5):340-3. doi: 10.4166/kjg.2010.55.5.340.

DOI:10.4166/kjg.2010.55.5.340
PMID:20697195
Abstract

Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer. Among known toxicities induced by oxaliplatin, hematological, gastrointestinal and neurological toxicities are common. However, acute pulmonary toxicity associated with oxaliplatin is unusual. One case of interstitial lung disease associated with the FOLFOX protocol is reported here.

摘要

奥沙利铂联合5-氟尿嘧啶加亚叶酸钙(FOLFOX)已成为结直肠癌患者的标准治疗方案。在奥沙利铂引起的已知毒性中,血液学、胃肠道和神经毒性较为常见。然而,与奥沙利铂相关的急性肺毒性并不常见。本文报告1例与FOLFOX方案相关的间质性肺疾病病例。

相似文献

1
[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].[与奥沙利铂、5-氟尿嘧啶和亚叶酸联合化疗相关的间质性肺疾病]
Korean J Gastroenterol. 2010 May;55(5):340-3. doi: 10.4166/kjg.2010.55.5.340.
2
Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).接受奥沙利铂、5-氟尿嘧啶和亚叶酸钙(FOLFOX)治疗的患者的间质性肺疾病
Int J Tuberc Lung Dis. 2006 Oct;10(10):1181-2.
3
Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.奥沙利铂所致间质性肺疾病。一种不常见但并非未知的并发症。
Arch Bronconeumol. 2017 Apr;53(4):213-215. doi: 10.1016/j.arbres.2016.08.010. Epub 2016 Oct 15.
4
[Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].两例接受奥沙利铂、5-氟尿嘧啶和亚叶酸钙(FOLFOX)治疗的患者出现间质性肺疾病
Gan To Kagaku Ryoho. 2009 Feb;36(2):295-8.
5
Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.FOLFOX + FOLFIRI与亚叶酸钙联合贝伐单抗治疗后发生的间质性肺疾病:一例报告
J Oncol Pharm Pract. 2018 Oct;24(7):540-543. doi: 10.1177/1078155217718616. Epub 2017 Jul 11.
6
Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).奥沙利铂、氟尿嘧啶和亚叶酸(FOLFOX)治疗后出现间质性肺炎。
Int J Clin Oncol. 2009 Oct;14(5):457-9. doi: 10.1007/s10147-008-0863-2. Epub 2009 Oct 25.
7
Interstitial lung disease associated with FOLFOX chemotherapy.与FOLFOX化疗相关的间质性肺疾病
J Cancer Res Ther. 2010 Oct-Dec;6(4):546-8. doi: 10.4103/0973-1482.77066.
8
Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.接受奥沙利铂化疗的结直肠癌患者并发嗜酸性粒细胞性肺病
Am J Clin Oncol. 2002 Aug;25(4):388-90. doi: 10.1097/00000421-200208000-00014.
9
The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.FOLFOX方案(亚叶酸钙、氟尿嘧啶与奥沙利铂联合)作为转移性结直肠癌一线治疗的疗效与毒性
Gan To Kagaku Ryoho. 2009 May;36(5):797-801.
10
Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.转移性结直肠癌的化疗:氟尿嘧啶加亚叶酸以及伊立替康或奥沙利铂。
Prescrire Int. 2005 Dec;14(80):230-3.

引用本文的文献

1
Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.FOLFOX治疗相关间质性肺炎的预后与治疗:呼吁对呼吸功能不全患者采用多模式免疫调节治疗
BMC Cancer. 2017 Aug 29;17(1):586. doi: 10.1186/s12885-017-3576-y.
2
Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer.奥沙利铂、氟尿嘧啶和亚叶酸(FOLFOX)治疗转移性结直肠癌患者的间质性肺病。
Radiol Oncol. 2012 Dec;46(4):360-2. doi: 10.2478/v10019-012-0006-2. Epub 2012 Nov 9.